| Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT (R)) Mesenchymal Stromal Cell committee position statement on nomenclature |
57 |
| Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing |
29 |
| Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway |
29 |
| Cell, tissue and gene products with marketing authorization in 2018 worldwide |
25 |
| Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells |
21 |
| Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial |
21 |
| MSC-Exosome: A novel cell-free therapy for cutaneous regeneration |
21 |
| Exosome-transmitted LINC00461 promotes multiple myeloma cell proliferation and suppresses apoptosis by modulating microRNA/BCL-2 expression |
21 |
| MSCs-cells with many sides |
19 |
| Progress in the use of dental pulp stem cells in regenerative medicine |
17 |
| Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency |
16 |
| Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study |
15 |
| Cell sheet technology: a promising strategy in regenerative medicine |
14 |
| Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial |
14 |
| Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity |
14 |
| Manufacturing chimeric antigen receptor T cells: issues and challenges |
13 |
| Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers |
13 |
| Gene therapy for sickle cell disease: An update |
13 |
| Chimeric antigen receptor-T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods |
13 |
| Intramuscular administration potentiates extended dwell time of mesenchymal stromal cells compared to other routes |
11 |
| Manufacturing development and clinical production of NKG2D chimeric antigen receptor-expressing T cells for autologous adoptive cell therapy |
11 |
| Human induced pluripotent stem cell-derived lung progenitor and alveolar epithelial cells attenuate hyperoxia-induced lung injury |
10 |
| Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta |
10 |
| Intrastriatal transplantation of stem cells from human exfoliated deciduous teeth reduces motor defects in Parkinsonian rats |
10 |
| Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider |
10 |
| Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward |
10 |
| Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center |
10 |
| Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline |
9 |
| Bone marrow-derived mesenchymal stromal cells ameliorate severe acute pancreatitis in rats via hemeoxygenase-1-mediated anti-oxidant and anti-inflammatory effects |
9 |
| Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration |
9 |
| Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas |
9 |
| Current state of US Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon |
8 |
| Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile |
8 |
| Proceedings of the signature series symposium cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy, international society for cellular therapies, montreal, canada, may 2018 |
8 |
| HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice |
8 |
| Mesenchymal stem cells in the treatment of articular cartilage degeneration: New biological insights for an old-timer cell |
8 |
| Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway |
8 |
| Large-scale expansion of V gamma 9V delta 2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells |
8 |
| Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data |
7 |
| Manufacturing of human Wharton's jelly stem cells for clinical use: selection of serum is important |
7 |
| Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue |
7 |
| Gaps in the knowledge of human platelet lysate as a cell culture supplement for cell therapy: a joint publication from the AABB and the International Society for Cell & Gene Therapy |
7 |
| A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells |
7 |
| Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy |
7 |
| In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials |
7 |
| Morphological profiling using machine learning reveals emergent subpopulations of interferon-gamma-stimulated mesenchymal stromal cells that predict immunosuppression |
7 |
| Inducible indoleamine 3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells |
7 |
| Transplanted interleukin-4-secreting mesenchymal stromal cells show extended survival and increased bone mineral density in the murine femur |
7 |
| Identification of senescent cells in multipotent mesenchymal stromal cell cultures: Current methods and future directions |
6 |
| Mesenchymal stem cell-derived extracellular vesicles: a new impetus of promoting angiogenesis in tissue regeneration |
6 |
